Pfizer Solu-Medrol and Solu-Cortef Shortages Expected To Last Through 2004
Executive Summary
Pfizer expect to resolve shortages for its injectable glucocorticoids Solu-Cortef and Solu-Medrol in 2004
You may also be interested in...
P&U Kalamazoo Plant To Resume Sterile Drug Production In Two Weeks
Pharmacia & Upjohn will resume production of Solu-Medrol and 17 other sterile products at its Kalamazoo, Mich. plant within two weeks, the company said.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials